Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Clase Azul who wrote (5133)	8/6/1998 12:10:00 AM
From: Graystone	Read Replies (1) \| Respond to of 7041

He is unscrupulous or He is not reliable He is untrustworthy. All of these things are evidenced by his past history. Please take some time to look into this promoters past, you will discover a man that most people would not trust with their wallet. I will not support him in any fashion. I will also warn people about his unreliable character, his unscrupulous character and his untrustworthiness in financial matters, as evidenced by his past. Look at this thread. Listen to the Mysterious Linda Kaplan. There is no NDA before the FDA if you listen to her. Have you ever seen such a collection of vapid logic and mindless drivel as her posts this evening, from any person. Are you aware that this drug may be approved. Apparently she is not.

To: Clase Azul who wrote (5133)	8/7/1998 6:41:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

A good week for the shorts. ZONA is seriously overvalued at this level. Even if they ever got Vasomax approved, the sales would be so poor this company would never be worth more than $6-8 a share, IMO. After a bit of a flurry I would expect ZONA to continue down. Those who could have sold at 45 must be hurting now. I wouldn't be surprised if some brokers didn't lose their jobs over touting this poor stock. Any good research would have shown the drug didn't work well enough to be a money maker, IMO. Linda